Environmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, Avda. Sos Baynat s/n, 12071, Castelló de la Plana, Spain.
Environmental and Public Health Analytical Chemistry, Research Institute for Pesticides and Water, University Jaume I, Avda. Sos Baynat s/n, 12071, Castelló de la Plana, Spain; Applied Metabolomics Research Group, Hospital del Mar Research Institute, 88 Doctor Aiguader, 08003, Barcelona, Spain.
Anal Chim Acta. 2024 Nov 15;1329:343226. doi: 10.1016/j.aca.2024.343226. Epub 2024 Sep 10.
The use of new psychoactive substances (NPS) has emerged as a significant public health concern globally, due to their unknown and unpredictable effects on both physical and mental health. Among them, synthetic cannabinoids receptor agonists (SCRAs) currently stand as the most widely consumed NPS family in Europe. Since the detection of JWH-018 in 2008, the structures of these compounds have evolved to circumvent legislation and/or enhance their effects, consequently increasing the number of reported SCRAs to be monitored. Therefore, new strategies are needed to identify these compounds, whether in seized products or in biological samples.
This study presents the development of an open method for detecting SCRAs employing a "pseudo-target" screening approach, a strategy previously developed and used in our laboratory for synthetic cathinones identification. The methodology involves monitoring the main product ions and neutral losses derived from 179 SCRAs of the third and fourth generations, based on their fragmentation pathways. This approach allows for the tentative identification of the SCRAs, supported also by the created database. The versatility of the developed methodology is highlighted, extending its utility beyond seizure products or 'legal highs', to biological samples. In this sense, it has been successfully applied not only to the detection of SCRAs in research chemicals but also in authentic urine from an anonymous SCRAs consumer, through the identification of a metabolite.
This strategy will be particularly useful for the rapid detection of SCRAs in forensic and toxicological laboratories equipped with low-resolution MS/MS instrumentation. This is a valuable tool for the identification and monitoring of SCRAs across various contexts, significantly contributing to public health and forensic security efforts. It is especially beneficial for healthcare providers, enabling them to make informed treatment decisions.
新精神活性物质(NPS)的使用已成为全球关注的重大公共卫生问题,因为它们对身心健康的未知和不可预测的影响。其中,合成大麻素受体激动剂(SCRAs)目前是欧洲消费最广泛的 NPS 家族。自 2008 年检测到 JWH-018 以来,这些化合物的结构不断演变,以规避立法和/或增强其效果,从而导致需要监测的 SCRAs 数量增加。因此,需要新的策略来识别这些化合物,无论是在缉获的产品中还是在生物样本中。
本研究提出了一种用于检测 SCRAs 的开放式方法,该方法采用“伪目标”筛选方法,这是我们实验室以前开发并用于合成卡西酮识别的策略。该方法涉及监测第三代和第四代 179 种 SCRAs 的主要产物离子和中性损失,基于它们的断裂途径。这种方法允许对 SCRAs 进行暂定识别,也得到了创建的数据库的支持。所开发方法的多功能性得到了强调,将其应用范围扩展到缉获产品或“合法兴奋剂”之外,包括生物样本。在这方面,它不仅成功地应用于研究化学品中 SCRAs 的检测,还成功地应用于匿名 SCRAs 消费者的真实尿液中的代谢物的检测。
这种策略对于配备低分辨率 MS/MS 仪器的法医和毒理学实验室中 SCRAs 的快速检测将特别有用。这是识别和监测各种情况下 SCRAs 的宝贵工具,为公共卫生和法医安全工作做出了重大贡献。它特别有益于医疗保健提供者,使他们能够做出明智的治疗决策。